Celyad Oncology SA: Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate
Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) ("Celyad" or the "Company"), a clinical-stage biotechnology company focused on the discovery and development of chimeric
Source: finanznachrichten.de